A.P. Møller - Mærsk A/S
Transactions in connection with share buy-back program
Transactions in connection with share buy-back program
ANNOUNCEMENT
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
On 5 February 2025, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 14.4bn (around USD 2bn) to be executed over a period of 12 months. The second phase of the share buy-back program will run from 11 August 2025 up to 4 February 2026. The shares to be acquired will be limited to a total market value of DKK 7.2 billion (around USD 1.1 billion).
The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).
The following transactions have been made under the program in the period 22 December 2025 to 2 January 2026:
| Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
| Accumulated, last announcement | 154,925 | 1,918,729,629 | |
| 22 December 2025 | 570 | 14,538.5614 | 8,286,980 |
| 23 December 2025 | 500 | 14,437.9400 | 7,218,970 |
| 29 December 2025 | 375 | 14,584.0533 | 5,469,020 |
| 30 December 2025 | 470 | 14,582.5532 | 6,853,800 |
| 2 January 2026 | 600 | 14,655.6667 | 8,793,400 |
| Total 22 Dec 2025 - 2 Jan 2026 | 2,515 | 36,622,170 | |
| Accumulated in the second phase of the program | 66,971 | 887,286,709 | |
| Accumulated under the program | 157,440 | 1,955,351,799 | |
| Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
| Accumulated, last announcement (market and the Foundation) | 877,670 | 10,964,910,863 | |
| 22 December 2025 | 2,856 | 14,583.0725 | 41,649,255 |
| 23 December 2025 | 2,505 | 14,442.6467 | 36,178,830 |
| 29 December 2025 | 1,879 | 14,606.7988 | 27,446,175 |
| 30 December 2025 | 2,354 | 14,604.0867 | 34,378,020 |
| 2 January 2026 | 3,006 | 14,668.3716 | 44,093,125 |
| Total 22 Dec 2025 - 2 Jan 2026 | 14,249 | 207,792,664 | |
| Bought from the Foundation* | 1,649 | 14,582.9342 | 24,047,258 |
| Accumulated in the second phase of the program (market and the Foundation) | 379,454 | 5,040,770,872 | |
| Accumulated under the program (market and the Foundation) | 891,919 | 11,172,703,526 |
*)According to a separate agreement, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (the Foundation) participates on a pro rata basis to the shares purchased in the share buy-back program.
With the transactions stated above, the Company owns a total of 157,440 A shares and 1,007,973 B shares as treasury shares, corresponding to 7.36% of the share capital.
Details of each transaction are included as appendix.
Copenhagen, 5 January 2026
Contact persons:
Head of Investor Relations, Martin Dunwoodie, tel. +45 3363 3363
Head of Media Relations, Jesper Lov, tel. +45 6114 1521
Page 1 of 1
Attachments
- Announcement - Transactions in connection with share buy-back program - week 52 2025+1 2026
- Daily transactions in connection with share buy-back program - week 52 2025-1 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
GDU-TECH CO., LTD.7.1.2026 01:00:00 CET | Press release
GDU Launches UAV-P300, The World’s First Drone with AI-Driven Optical & Electronic Fog Penetration Capabilities
CNH Industrial N.V.6.1.2026 23:00:00 CET | Press release
Pricing of CNH Industrial Capital LLC $500 million notes
Alvotech6.1.2026 21:00:00 CET | Press release
Transactions of Managers and Closely Associated Persons
Alvotech6.1.2026 21:00:00 CET | Press release
Transactions of Managers and Closely Associated Persons
Zymeworks Inc.6.1.2026 19:34:22 CET | Press release
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom